Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-06 · accession 0001437749-23-000698 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-09 | 2023-01-06 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $31.30 | +3,195 | 19.9K | +19% | +$100.0K |
| D | 2023-01-09 | 2023-01-06 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $0.00 | -3,195 | 14.1K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-06 | M | A | 3,195 | $31.30 | 19,937 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-01-06 | M | D | 3,195 | $0.00 | 14,108 | D | $31.30 · 2017-12-22 to 2024-12-22 | 3,195 Common Stock | (F2) This option is fully vested and exercisable. |